Clinical trial shows promising results for PanChol, a single-dose oral vaccine aimed at the up to 4 million annual cholera ...

The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...

The company confirmed the publication of its successful clinical case series in Frontiers in Immunology, a peer-reviewed scientific journal, and received confirmation from the U.S. Food and Drug ...

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...

TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated to improving the health of people around the world by accelerating and simplifying clinical research, today announced the ...

WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the ...

As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate pelacarsen to a Phase III test of Eli Lilly’s next-gen Alzheimer's drug—are poised ...

Texas allocates $50 million to UT-led IMPACT partnership for ibogaine clinical trials treating PTSD, addiction, and more.

To be accepted into a clinical trial, all potential participants must meet the "eligibility criteria" by having similar ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

Reem Hospital today announced the successful completion and database lock for its clinical trial, the TauRx TRx-237-805 study ...